STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more (opens in new tab)

Covers 2 stories including Phase III HUMAN study shows that new pill for patients with advanced pancreatic cancer live significantly longer than standard chemotherapy

Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall survival, from 13.2 months to 6.7 months

Read the original article